Early Net Ultrafiltration during Continuous Renal Replacement Therapy: Impact of Admission Diagnosis and Association with Mortality
Blood Purification · 2024
DOI: 10.1159/000535315 ↗Kurz gefasst
Fachartikel in der Zeitschrift Blood Purification, 2024. Verfasst von Benjamin Sansom und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Intensive Care, The Royal Melbourne Hospital, Melbourne, Victoria, Australia, benjamin.sansom@mh.org.au. Hauptthemen laut MEDLINE: Continuous Renal Replacement Therapy, Kidney Failure, Chronic, Acute Kidney Injury. Die Arbeit wurde bisher 8-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Introduction
Continuous renal replacement therapy (CRRT) is common in the intensive care unit (ICU) but a high net ultrafiltration rate (UFNET) calculated with daily data may increase mortality. We aimed to study early UFNET practice using minute-by-minute CRRT machine recordings and to assess its association with admission diagnosis and mortality.
Methods
We studied CRRT treatments in three adult ICUs over 7 years. We calculated early UFNET rates minute-by-minute and categorized UFNET into tertiles of mean UFNET in the first 72 h and admission diagnosis. We applied Cox-proportional hazards modelling with censoring of patients who died within 72 h.
Results
We studied 1,218 patients, 154,712 h, and 9,282,729 min of CRRT (5,702 circuits). Mean early UFNET was 1.52 (1.46–1.57) mL/kg/h. Early UFNET tertiles were similar to, but somewhat higher than, previously reported values at 0.00–1.20 mL/kg/h, 1.21–1.93 mL/kg/h, and >1.93 mL/kg/h. UFNET values were similar whether evaluated at 24 or 72 h or for the entire duration of CRRT. There was, however, significant variation in UFNET practice by admission diagnosis: higher in respiratory diseases (pneumonia p = 0.01, other p < 0.0001) and cardiovascular disease (p = 0.005) but lower in cardiothoracic surgery (p = 0.04), renal (p = 0.0003) and toxicology-associated diagnoses (p = 0.01). Higher UFNET was associated with an increased hazard of death, HR 1.24 (1.13–1.37), independent of admission diagnosis, weight, age, sex, presence of end-stage kidney disease, and severity of illness.
Conclusion
Early UFNET practice varies significantly by admission diagnosis. Higher early UFNET is independently associated with mortality. Impacts of UFNET on mortality may vary by admission diagnosis. Further work is required to elucidate the nature and mechanisms responsible for this association.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Intensive Care, The Royal Melbourne Hospital, Melbourne, Victoria, Australia, benjamin.sansom@mh.org.au.
- Department of Critical Care, The University of Melbourne, Melbourne, Victoria, Australia, benjamin.sansom@mh.org.au.
- Department of Intensive Care and Hyperbaric Medicine, The Alfred, Melbourne, Victoria, Australia.
- Australian and New Zealand Intensive Care Research Centre, School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.
- Department of Intensive Care, The Royal Melbourne Hospital, Melbourne, Victoria, Australia.
- Department of Critical Care, The University of Melbourne, Melbourne, Victoria, Australia.
Zitieren
APA
Sansom, B., Udy, A., Presneill, J., & Bellomo, R. (2024). Early Net Ultrafiltration during Continuous Renal Replacement Therapy: Impact of Admission Diagnosis and Association with Mortality. Blood Purification. https://doi.org/10.1159/000535315
Vancouver
Sansom B, Udy A, Presneill J, Bellomo R. Early Net Ultrafiltration during Continuous Renal Replacement Therapy: Impact of Admission Diagnosis and Association with Mortality. Blood Purification. 2024. doi:10.1159/000535315
BibTeX
@article{Sansom2024,
author = {Sansom, Benjamin and Udy, Andrew and Presneill, Jeffrey and Bellomo, Rinaldo},
title = {Early Net Ultrafiltration during Continuous Renal Replacement Therapy: Impact of Admission Diagnosis and Association with Mortality},
journal = {Blood Purification},
year = {2024},
doi = {10.1159/000535315}
}
EUVIMED